P Novak Selected Research

P Novak Research Topics

2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
2	Cognitive Dysfunction 01/2020 - 01/2019
2	Neoplasms (Cancer) 10/2016 - 03/2012
2	Colorectal Neoplasms (Colorectal Cancer) 10/2016 - 03/2012
2	Parkinson Disease (Parkinson's Disease) 07/2016 - 09/2001
2	Infarction (Infarctions) 05/2005 - 05/2001
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Weight Gain 01/2022
1	Dementia (Dementias) 01/2020
1	Insulin Resistance 01/2020
1	Tauopathies 01/2019
1	Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia) 01/2019
1	Injection Site Reaction 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Cartilage Diseases (Cartilage Disease) 01/2017
1	Osteoarthritis 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016
1	Ischemic Stroke 01/2010
1	Pneumoperitoneum 09/2001
1	COVID-19 related adult multisystem inflammatory disease 01/2000

2	Insulin (Novolin)FDA Link 01/2022 - 01/2020
1	InsulinsIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2019
1	AADvac1IBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 10/2016
1	isooctyl acrylateIBA 07/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Asparaginase (Elspar)FDA Link 01/2016
1	Glutamine (L-Glutamine)FDA Link 01/2016
1	AsparagineIBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 03/2012
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2012
1	Antineoplastic Agents (Antineoplastics)IBA 03/2012
1	cerebrolysinIBA 01/2010
1	HemosiderinIBA 05/2005
1	Dopamine Agonists (Dopamine Agonist)IBA 09/2001
1	Oxygen (Dioxygen)IBA 09/2001
1	HeliumIBA 09/2001
1	Levodopa (L Dopa)FDA LinkGeneric 09/2001
1	Pramipexole (Mirapex)FDA LinkGeneric 09/2001
1	serpentine (alkaloid)IBA 05/2001
1	IronIBA 05/2001

5	Therapeutics 01/2020 - 09/2001
3	Drug Therapy (Chemotherapy) 10/2016 - 09/2001
1	Microelectrodes 07/2016
1	Deep Brain Stimulation 07/2016
1	Minimally Invasive Surgical Procedures 01/2000